Similares a Tegoprubart Sustains Increased eGFR Longterm Compared to Tacrolimus

20 vecinos (text_768) · 114 views · HCPLive · Estados Unidos


★	Tegoprubart Sustains Increased eGFR Longterm Compared to Tacrolimus	HCPLive @hcplivenews	114	Estados Unidos
8	Phase 3 VISIONARY: Sibeprenlimab May Preserve #KidneyFunction in IgA Nephropathy	HCPLive @hcplivenews	981	Estados Unidos	84
19	Is Long-Term JAK Inhibitor Use Safe for #Alopecia Areata?	HCPLive @hcplivenews	456	Estados Unidos	83
6	SGLT2 EN ERC Beneficio en todos los estadios	ENSEÑANDO MEDICINA INTERNA @carloswaldomi	383	—	85
7	Interim Phase 3 VISIONARY Data Show Sibeprenlimab Preserved Kidney Function in IgA Nephropathy	HCPLive @hcplivenews	233	Estados Unidos	84
16	Provider Connections: Dr. Nora Bennani on Relapsed Refractory T-Cell Lymphoma	Mayo Clinic @mayoclinic	208	Estados Unidos	83
5	Kidney Compass: VISIONARY 2-Year eGFR Data in IgA Nephropathy	HCPLive @hcplivenews	199	Estados Unidos	85
2	Functional Cures for T1D: Insulin Independence Through Islet Transplantation	HCPLive @hcplivenews	185	Estados Unidos	87
20	Diabetes Dialogue: CKM Systems, Triple Agonists, and a Sensor Scandal Ahead of ADA	HCPLive @hcplivenews	179	Estados Unidos	83
4	All 12 Tegoprubart Recipients Off External Insulin Following Islet Implant in Pilot Study	HCPLive @hcplivenews	168	Estados Unidos	86
1	Diabetes Dialogue: Tegoprubart and Freedom from Insulin in Type 1 Diabetes	HCPLive @hcplivenews	143	Estados Unidos	88
11	FIND-CKD Expands Finerenone Evidence Beyond Diabetic CKD, With Rajiv Agarwal, MD	HCPLive @hcplivenews	131	Estados Unidos	83
12	Obinutuzumab Achieves 95.5% Remission in INS, May Shift Steroid-Sparing Treatment Strategies	HCPLive @hcplivenews	109	Estados Unidos	83
10	GLP-1s Move Beyond Diabetes as Core Kidney-Protective Therapy	HCPLive @hcplivenews	80	Estados Unidos	83
15	Bimekizumab Data Support Case for Earlier Intervention in HS	HCPLive @hcplivenews	78	Estados Unidos	83
14	Crinecerfont Sustains Glucocorticoid Reduction, Improves Cardiometabolic Outcomes in Classic CAH	HCPLive @hcplivenews	74	Estados Unidos	83
18	Avapritinib's 4-Year Impact on Quality of Life in ISM \| Thanai Pongdee, MD	HCPLive @hcplivenews	73	Estados Unidos	83
13	Diabetes Dialogue: Teplizumab, Stelo, and Inhaled Insulin Afrezza for Pediatric Patients	HCPLive @hcplivenews	53	Estados Unidos	83
3	Update 3a edición. In personalized immunosuppression	Hospital Universitari de Bellvitge @bellvitgehospital	35	España	86
9	Continuous Ketone Monitoring May Guide SGLT2i Use in T1D	HCPLive @hcplivenews	33	Estados Unidos	84
17	BE HEARD EXT: Bimekizumab Shows Greater Benefit With Earlier Use in HS	HCPLive @hcplivenews	14	Estados Unidos	83